Biosimilars offer real cost savings on expensive biologic drugs-up to 85% off list prices in some cases. Learn how they compare to originators, why savings are still limited, and how patients and employers are benefiting.
Biosimilars offer real cost savings on expensive biologic drugs-up to 85% off list prices in some cases. Learn how they compare to originators, why savings are still limited, and how patients and employers are benefiting.